Agilent Technologies Signs Agreement to Acquire Lasergen, Inc.

Agilent Technologies Signs Agreement to Acquire Lasergen, Inc. Acquisition affirms Agilent’s strategic intent to grow in the diagnostics space and build a complete routine clinical NGS workflow SANTA CLARA, Calif., April 3, 2018 Agilent Technologies Inc. (NYSE: A) and Lasergen, Inc. (Lasergen) today announced that they have signed a definitive agreement for Agilent to acquire... Read more

Waters Corporation to Invest $215 Million in Precision Chemistry Manufacturing in Massachusetts

New State-of-the-Art Facility Will Support Continued Growth and Innovation MILFORD, Mass.–(BUSINESS WIRE)–Apr. 3, 2018– Following recent approval by its Board of Directors, Waters Corporation (NYSE: WAT) announced plans to significantly expand its precision chemistry operation in Taunton, Mass. The company anticipates investing approximately $215 million to build and equip a new state-of-the-art facility that will support rising global customer demand, as... Read more

Rapid Mycoplasma Testing Method Now Accepted by Regulators for QA/QC and Lot Release

Rapid Mycoplasma Testing Method Now Accepted by Regulators for QA/QC and Lot Release MycoSEQ Mycoplasma Detection Method can accelerate production timelines for manufacturers of cell and gene therapies, biotherapeutics, vaccines and other cell-culture-based modalities BEDFORD, Mass., April 3, 2018 /PRNewswire/ — Manufacturers of cell-culture-based therapeutics can now rely on a faster method for detecting mycoplasma contamination.... Read more

VICAM Introduces a New Method for BPA Detection

BPATest enables food and agricultural laboratories to isolate and purify BPA for analysis in as little as ten minutes MILFORD, Mass.–(BUSINESS WIRE)–Mar. 29, 2018– Waters Corporation (NYSE:WAT) announced VICAM®, a Waters® Business, introduced a sensitive, precise determination of Bisphenol A (BPA) for food and agricultural laboratories. VICAM’s BPATest™ quickly isolates and purifies BPA for analysis from 0.1 to 50 parts... Read more

Thermo Fisher Scientific Sponsors Precision Medicine Summit in China

One-day event in Beijing convened more than 400 leaders from government, academia and industry to discuss precision medicine advancement BEIJING, March 29, 2018 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today sponsored the first China-U.S. Precision Medicine Summit, along with co-hosts CEO Roundtable on Cancer, China Academy of Medical Sciences and... Read more

Exactis Innovation Selects Ion GeneStudio S5 Systems and Oncomine Assays to Drive Canadian Clinical Trial Studies

Exactis Innovation Selects Ion GeneStudio S5 Systems and Oncomine Assays to Drive Canadian Clinical Trial Studies Laboratory network standardizes on common NGS platform to efficiently profile patient samples across multiple cancer centers CARLSBAD, Calif., March 28, 2018 /PRNewswire/ — At risk cancer patients across Canada may now be able to have their tumors molecularly profiled... Read more

New Salmonella Multiplex PCR Solution for Simultaneous Detection of Three Salmonella Targets in One Rapid Test is Now Certified by AFNOR

New Salmonella Multiplex PCR Solution for Simultaneous Detection of Three Salmonella Targets in One Rapid Test is Now Certified by AFNOR Real-Time PCR workflow gains NF VALIDATION by AFNOR Certification for rapid and simultaneous detection of Salmonella species, Salmonella Typhimurium and Salmonella Enteritidis BASINGSTOKE, England, March 27, 2018 /PRNewswire/ — Laboratories performing tests for poultry producers... Read more

BIRAC and PerkinElmer Sign Letter of Intent to Promote India-Led Startups and Innovations

NEW DELHI–(BUSINESS WIRE)–The Biotechnology Industry Research Assistance Council (BIRAC) celebrated its 6th Foundation Day on Tuesday in New Delhi. The event, aptly themed ‘Sustaining Innovation: A Market Driven Pathway’, was presided over by the Hon’ble Minister of State for Science and Technology & Earth Sciences, Dr Harsh Vardhan, Prof. Ashutosh Sharma, Secretary, Department of Biotechnology... Read more

CMS and Commercial Insurers Extend Coverage of Oncomine Dx Target Test to more than 160 Million U.S. Lives

CMS and Commercial Insurers Extend Coverage of Oncomine Dx Target Test to more than 160 Million U.S. Lives Payors reimburse first NGS, FDA-approved test for non-small cell lung cancer to expedite targeted therapy selection for patients CARLSBAD, Calif., March 19, 2018 /PRNewswire/ — Thermo Fisher Scientific today announced its Oncomine Dx Target Test has been approved for... Read more

Thermo Fisher Scientific Acquires IntegenX, Provider of Leading Rapid DNA Technology for Human Identification

Thermo Fisher Scientific Acquires IntegenX, Provider of Leading Rapid DNA Technology for Human Identification CARLSBAD, Calif., March 16, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has acquired IntegenX Inc., which provides a rapid DNA platform for use in forensics and law enforcement applications. IntegenX products significantly... Read more